[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100077478":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":7,"locations":16,"responsibleParty":121,"collaborators":7,"id":123,"slug":124,"hasResults":125,"nctId":126,"briefTitle":127,"officialTitle":128,"acronym":7,"eligibilityCriteria":129,"healthyVolunteers":130,"sex":131,"minAge":132,"maxAge":133,"enrollmentInfo":134,"targetDuration":7,"studyType":137,"phases":138,"briefSummary":140,"conditions":141,"keywords":7,"overallStatus":145,"whyStopped":7,"lastUpdateSubmitDate":146,"lastUpdatePostDateStruct":147,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":155},{"fullName":5,"class":6},"GlaxoSmithKline","INDUSTRY",null,[9],{"type":10,"name":11,"description":7,"armGroupLabels":7,"otherNames":7},"BIOLOGICAL","Prophylaxis: Diphtheria, tetanus and pertussis",[13],{"name":14,"affiliation":5,"role":15},"GSK Clinical Trials","STUDY_DIRECTOR",[17,30,38,47,56,64,72,81,89,98,103,108,113],{"facility":18,"status":7,"city":19,"state":20,"zip":21,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":7},"GSK Investigational Site","Kehl","Baden-Wurttemberg","77694","Germany","DE",{"type":25,"coordinates":26},"Point",[27,28],7.81523,48.57297,{"lat":28,"lon":27},{"facility":18,"status":7,"city":31,"state":20,"zip":32,"country":22,"countryCode":23,"cosmosGeoPoint":33,"geoPoint":37,"contacts":7},"Oberkirch","77704",{"type":25,"coordinates":34},[35,36],8.07864,48.53241,{"lat":36,"lon":35},{"facility":18,"status":7,"city":39,"state":40,"zip":41,"country":22,"countryCode":23,"cosmosGeoPoint":42,"geoPoint":46,"contacts":7},"Limburg an der Lahn","Hesse","65549",{"type":25,"coordinates":43},[44,45],8.0503,50.3836,{"lat":45,"lon":44},{"facility":18,"status":7,"city":48,"state":49,"zip":50,"country":22,"countryCode":23,"cosmosGeoPoint":51,"geoPoint":55,"contacts":7},"Erkrath","North Rhine-Westphalia","40699",{"type":25,"coordinates":52},[53,54],6.90831,51.22235,{"lat":54,"lon":53},{"facility":18,"status":7,"city":57,"state":49,"zip":58,"country":22,"countryCode":23,"cosmosGeoPoint":59,"geoPoint":63,"contacts":7},"Krefeld","47798",{"type":25,"coordinates":60},[61,62],6.55381,51.33645,{"lat":62,"lon":61},{"facility":18,"status":7,"city":65,"state":49,"zip":66,"country":22,"countryCode":23,"cosmosGeoPoint":67,"geoPoint":71,"contacts":7},"Willich","47877",{"type":25,"coordinates":68},[69,70],6.54734,51.26371,{"lat":70,"lon":69},{"facility":18,"status":7,"city":73,"state":74,"zip":75,"country":22,"countryCode":23,"cosmosGeoPoint":76,"geoPoint":80,"contacts":7},"Mainz","Rhineland-Palatinate","55131",{"type":25,"coordinates":77},[78,79],8.28008,49.98185,{"lat":79,"lon":78},{"facility":18,"status":7,"city":82,"state":74,"zip":83,"country":22,"countryCode":23,"cosmosGeoPoint":84,"geoPoint":88,"contacts":7},"Trier","54290",{"type":25,"coordinates":85},[86,87],6.63935,49.75565,{"lat":87,"lon":86},{"facility":18,"status":7,"city":90,"state":91,"zip":92,"country":22,"countryCode":23,"cosmosGeoPoint":93,"geoPoint":97,"contacts":7},"Flensburg","Schleswig-Holstein","24937",{"type":25,"coordinates":94},[95,96],9.43722,54.78805,{"lat":96,"lon":95},{"facility":18,"status":7,"city":90,"state":91,"zip":99,"country":22,"countryCode":23,"cosmosGeoPoint":100,"geoPoint":102,"contacts":7},"24939",{"type":25,"coordinates":101},[95,96],{"lat":96,"lon":95},{"facility":18,"status":7,"city":90,"state":91,"zip":104,"country":22,"countryCode":23,"cosmosGeoPoint":105,"geoPoint":107,"contacts":7},"24943",{"type":25,"coordinates":106},[95,96],{"lat":96,"lon":95},{"facility":18,"status":7,"city":90,"state":91,"zip":109,"country":22,"countryCode":23,"cosmosGeoPoint":110,"geoPoint":112,"contacts":7},"24944",{"type":25,"coordinates":111},[95,96],{"lat":96,"lon":95},{"facility":18,"status":7,"city":114,"state":91,"zip":115,"country":22,"countryCode":23,"cosmosGeoPoint":116,"geoPoint":120,"contacts":7},"Husum","25813",{"type":25,"coordinates":117},[118,119],9.05239,54.4858,{"lat":119,"lon":118},{"type":122,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100077478","phase-3-assessment-of-gsk-biologicals-tdap-candidate-vaccine-administered-as-a-booster-6th-dose-in-terms-of-immunogenicity-and-safety-to-children-and-adolescents-previously-vaccinated-with-five-doses-of-an-acellular-pertussis-containing-vaccine-100077478",false,"NCT00263679","Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.","A Phase III, Double-blinded, Randomized, Multicenter, Clinical Study to Assess the Safety and Immunogenicity of GSK Biologicals' Tdap 0.3 mg Candidate Vaccine When Given as a Booster Dose to Healthy School Children and Adolescents (9-13 Years of Age), Previously Vaccinated With a 5th Consecutive Dose of Acellular Pertussis-containing Vaccine, in Studies APV-118 or APV-120","Inclusion Criteria:\n\n\\- Subjects previously enrolled and vaccinated in GSK Biologicals' studies APV-118 and APV-120 and who were 9 through 13 years of age\n\nExclusion Criteria:\n\n* Use of any investigational or non-registered drug or vaccine other than the study vaccines within 30 days preceding the administration of study vaccines, or planned use during the study period.\n* Chronic administration or planned administration of immunosuppressants or other immune modifying drugs within six months prior to study vaccination or planned administration during the study period\n* Administration of immunoglobulins and\u002For blood products within 3 months prior to vaccination",true,"ALL","9 Years","13 Years",{"count":135,"type":136},321,"ACTUAL","INTERVENTIONAL",[139],"PHASE3","The aims of this study are to evaluate the safety and immunogenicity of a booster dose of GSK Biological's candidate Tdap vaccine containing 0.3 mg Al when administered to healthy school children and adolescents (9-13 years of age) previously vaccinated with five consecutive doses of Pa-containing vaccine. The inclusion of hepatitis A vaccine (Havrix®) as a control vaccine enables this study to be conducted in a double-blinded in terms of immunogenicity and safety assessments.",[142,143,144],"Acellular Pertussis","Diphtheria","Tetanus","COMPLETED","2016-09-14",{"date":148,"type":149},"2016-09-15","ESTIMATED",{"date":151,"type":7},"2003-11",{"date":153,"type":136},"2004-10",{"name":5,"class":6},13]